pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-628 |
Genomic Coordinates | chr15: 55372940 - 55373034 |
Synonyms | MIRN628, hsa-mir-628, MIR628 |
Description | Homo sapiens miR-628 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-628-3p | ||||||||||||||||||||||||||||
Sequence | 61| UCUAGUAAGAGUGGCAGUCGA |81 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Microarray | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RBFOX2 | ||||||||||||||||||||
Synonyms | FOX2, Fox-2, HNRBP2, HRNBP2, RBM9, RTA, dJ106I20.3, fxh | ||||||||||||||||||||
Description | RNA binding protein, fox-1 homolog 2 | ||||||||||||||||||||
Transcript | NM_001031695 | ||||||||||||||||||||
Other Transcripts | NM_001082576 , NM_001082577 , NM_001082578 , NM_001082579 , NM_014309 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RBFOX2 | |||||||||||||||||||||
3'UTR of RBFOX2 (miRNA target sites are highlighted) |
>RBFOX2|NM_001031695|3'UTR 1 AGTGACGTGAGACCCCTGCAAATGGGACAGCCCCCCAGTTCATGAGGCCTGGCTATTGCAATATTTACTAGTAGAGGAAC 81 TCTATAGCAAGATGAAGAGGAAAAACAAACAAACAAACAAAAAAAAACACAAAAAAAGAAAGAATACTTTTTTATACCTC 161 ACTATGTTCTTTGAATATGTATTTTTCCTTTAAATTTCTGCCTTTAATTCTTTTGTTCCAAAGATTGTGCATTTTTTTCT 241 TTTTTTTTTTAAACTGTGGTAAAAAAAAAAAAAATAATGCATTTCCATGTCTGTATGTCCGTGCTTAGCTTATTCTATCA 321 ATCACGGAAGAGGCAGTCAAGGAGGAAGGAGAGACATTAGGAGCCGATAAATGCATCTGATCAGAAATCAGCAGACAGAA 401 TTACCAAAGTGTATCTGGTGCTGAATGACTGGGGGACAAGCAGAAGTGGAAGAGATCTTTCTGCAACAGGATATTCTTCT 481 AGTCTTCTGAGTTTCTGGTCTTTGACAGGCAATTCTGGTTGGCTGTGGCTGGAATCCACATGCTGATAGATAGGAATTTG 561 TGCTTACAAAGCAGGAGAATTAAAAAGACGCTTTCCTCTCCTCTTCCCTCCTGTCTTCTCCGTTCTTTTTACAATCATCT 641 TACACGCACAGCCTGAGACAGCTGGCATAGTTTTTGGAATTATAGTATTGATATTTCCAAACGTGCTCTCAGACAGTGGA 721 TAATAAACACCTCATTAGGAAACCGATCTCAGAATGAACTCTGGAGTATGAAAAAGATCATTTCTTTTTGTTCCTGTAAC 801 CTAGCATTCCTTCTAGGCTTCTTCTCCTTTAATTGAACCACAGCTTAGCTCATGTATTCTTTTATTAACACCCTGCTCTC 881 ATGTCCATAAGATTCAGGAATTTAGGACCCAGGGACAGAAAAGTGAATAAGCCAGTGACCAGATTTCCCCCAGATGTCTT 961 GAGGATTAGAAGTACAAATTGTTGACAGCCATTAAAGAGGGTGAGGAAGGGAAAAGGAATATTAGAAGATCTGGTATTTC 1041 TTACTTTTTTCTTGCCTCAGAAAGTACAAAGTTTAAAAAATAGAATAAAGAATCTGCTGGGGAAAGATAGAGTACCAGGT 1121 CCTAGGTCAGTAGTCCCTGGAAGTTTTGGTGATGAGGACATGGAAGGGCAGGCAGAGGCACTTTGTACTTGCTCCAAAGC 1201 CATAGGAATTTTCATCTTCCAGAGCCTTTATGAGTCACTTCTCTATCCACAGTCTTGAGCCTGTGGCTATCCCGCTGAGC 1281 TTCTCACTGTCCTCCAAAAACACCCCGCTGAGCACCCGGACCACTTTGTACACATTAACACTACAGGACATAAAATGCAG 1361 AGGCCCTGAGATTGCTGCCCTCCCATATTGGAAGGAGGGTCTGCGATGGCAAGGGTCTTCTATATCACCAGAAAGAGTCG 1441 CGCAGTGAGTCACTGCCGTTGCCATCTGGCTGTAATTTTCTATGTTATCAAGGTAGGAGGGAGTGTTTCTCTTCTAGCTG 1521 TTAGATAGAACTGATAAAAGCAAGTGTCCTACAGCATTTCCCAAATGAAGGCATTAGGAAATAGAAAAGCACGGTCTTTT 1601 TGGCTCCCTGGTCTAGTCACATTGGTACTAGGGTGACCTTTCACCCAAGGGACAGCTGCTAAAGGGAGTAATTCAGAGAC 1681 ATGGAGCTTCTGGTTATGGGTTTGTTTTGGGTTTGTTTTTAACTCCTGCCTCCACACATGTTCTTGACTGATAACTGACT 1761 CATGTCCCTGAATTAAAATGACTGACCTATGACAGCATCAAGCATTCTTTGTAAGCAGAGTGATATATCTGAGAGGGCGT 1841 TGACCTGTTGTGTAGAATACATATCCTTTCCCCCTTCAGAATCCTGTCTCGCCTCGTAACTGGGAGAGAGGCTGTGCCTG 1921 AAACTAGGGGCGATGTCAAGGAAGCTAGAGGCCTCGATGCAATTATTACTGACTCTGGGGAGGAAGACAGAGAATAAGGG 2001 GACACCAACTGCCCAGTCCACTGGCCATTTTTAAGGGTCCCCCCACCCCAAGCCAAAGTTTGGTTTGTTGCTGTTAAGAC 2081 AATTTTTGTTGTATGTATATAAATATTTTAGTTAGAGGAGCGGGGAATGGGATGCGGGCTTTCACAGTTCTAGGGAATGG 2161 GGGCAGGGAGGATTTTGCTTTTGCTTTTGCTTTGAGGGAGAACTTTAGCTGACTAAAAAAACAGAAGTTTGGGGTCATGA 2241 TCACAAAGGGGCCATTCCCAAAAGATGGCAAGCCACGTATTCAGTGGAGACTAGGCCAAATTCTAAATGGTTTTATCCAT 2321 AGCAGGGGAGAATAGGAGAATGAGTTTAAGAGTTTTTCTCTTCTTTTTTCCTAGAAAGAGGTAAGGATAATGGGAAAGGT 2401 AGAGAAGGCGGCTCCCACAGACCTTTTAAGAGAGGCAGAATCTTGAGCTTGAGGCACCTTGAGTGCATCTCAGTTCAGCT 2481 GGTTCTGGCTGAGGCCTCCAAAGGCAAGCTCTGTGCTTTCCAGTGGTTTCTGCTGCATTTCCAGGGATGGTGTTTAACAC 2561 CGCTTCCTCCAGCTCCCTTTTCTAAGAAAGAATAAATGGAGTTCTGCTTTTTATGAAAGGGTCTTTGGTTTTCAGTGTCA 2641 ACACTGAGAATTGGGGCTCTTGCAAGCATCTGGATTTCACAGTATCAACCTCCCCGTCACCTTTTGAACTTTGAGACTCC 2721 GTACGGTCAACTTCACCAGAGGCAGGTTGCTCGAAGCAGCACTGCTTGTCTGTTCCTGACTCTGGTTCTCACTGTATTAA 2801 AAAAGAGAGTCAGAGGAGTCTGGCATTTCGTGAGTTTGTTAGAGGATGCTGGCTGATAATTCCAGAAAACTTACTGATGC 2881 TAAATCACAGTACATGCATGATTCTTTTTCAGCTTTACTATAGTTCATGACCTGGACTTTCTGTACTCTTGGAAGCTGGG 2961 CTCCTTAAAGGAGGCCTCTAGTGAACACCTTTATCTCCATGTCCCTCTTAGAGCCCAGAGAGCTGCCCATAGGCATTTTC 3041 CAGAATTCCTCATGTCACCTAGTTCAATTTCCATTAACTCAGATCAGCCATTGTGATTCACCATTTGTCAGGCTCTCAGG 3121 TTTAACAAAACCTACTATCACCATCATCCTTCAACAGCCACAGTCTGAATTGAGCCAACATTTTTTTTTCTTTGAGAAAG 3201 AAGTGGACTGGGGCACAACTTTTAGTCTGAGGGGAGCTAGTGGAAATCTAGACAATAGAAGTCATCGATAGCAGCTTTTC 3281 CTCAAATGTGTGACTCCTCAGGGGCTAAACTGCTCTTAGCTTAGAATTATGCTTTACTAGAGATCTAGCAGATAAGTGGG 3361 TTAATCACTACCATCCTGTAACTAGTTATATAGCTTCCAGACATGAGGGAGACATCAAACAGGGATGGAAGCAACCCCAA 3441 GGATATGCAAGAAGGGCATGATGAACCCCCTTCCCTCTGGCAGGAGAACAAGGCCAACCAAGGGACAGACTGGAAAGCAC 3521 TTAGATGTTTAAGGAGGAGAAAGGGGAAGCTTTGACCAGTCCTTGCCTTTTGCCAAGTTCAGCCAGTTCTCCGCTGCTTG 3601 CAACCTCTAGCGCAGTAACATTTGCAGAATTGCAGATTTTCCCCCAGATACTAGGAGGAAAGGGACTTTGGGGGGTGGGG 3681 AAGGGGTCGTGGTGTTTTAAAAGCATAAGTTACCTGTTTGCACTGTTTTAAGATAGGAAAAAAAAATAGTGGGCAAGGTG 3761 AACATCAGACGTAAATTTGTGTGTTTTTATTTTGTCATGCTCTTGAAAATGTTTGACCATTTGTAGTATACACAGTGAAA 3841 CTTGATTCTCTGTTGCATAAAACACTATATTTTTTTGGAAATGTTACTGTCCAAAAGCCTCTTCCCTCCCTTTCCTTTTC 3921 CTATGTACTTCCTTCATACTTGCTTTACTGATCAGCCAGGCAATAGCCATCCAAGAGCTAGAGCATGAAACAGGGCCCTT 4001 TCCAAGTAGGCTCTGGGTGTCCTAAGCCAGCGTGTGCCCTCTGGTTTAGTGAGTGTAATAGAGTCCCTGGCACCTTTCTT 4081 TGCAAATGAGGCTAACAGACCAGACTGCAGCAAGTTATCAGATTCCTCAATCAGATGCACTAGGAGTGAGGAGCCCAGGG 4161 ATGGAGGGGGTTCCTGAAGTATTGCAGTTGGCTGTAGTAGCTGAGTTCTTTTCCATGTTACCGAAACTGTAGCCAGTTAC 4241 AGTTTACTCAGGAAAACGGTAGATCAATTCAGCCATGGTAGTGCTGGTTGGCAGGGATTGGTAACGGAGAGAACTGCTCA 4321 TCAGCCAAAACTCAAGCCTTGCCTTTTAGGAGGCCACCAGCAGAGGGACTTGGTCCTCCTTGTCTGGTACTTGTGTACAT 4401 GCCGGTGACCTGAGGACTCCACTCACACTGGCGAGCAAAAAGGGAGCAGTGATTCTCTTTTCTCTCCCCACCCCCTGCCC 4481 TTTGTTACCAACACCAGTTTCCCAGGGGGTACATGAGTTTCTGAATTTTTAAAAAATGTTTTTGGTTTGGTTTTTCTGGG 4561 GACTGATAAGTGCTTTAAGCAATGTCCATACCCCGTCAAGACTCCCAGCTTAGTCATTTTCTTGTATTTTTCTGTTCACA 4641 GTATTTGTGTGTGTGCTTGTTTTGGCAGCTCATTTTGGCTGTATTATATATTGAGTGATGAATTGATCCTCTTTTTTCCC 4721 TAAGGGATATGAATTGTTTTTCTTGTGTTATATTCTGCTTGTGAATAGCTGGAGCAAACCTGGGGCTGACACGCGTAAGC 4801 TAGGGCTGCAAAGCGAGAAGAGAGCCGGTGGAGTGTACTTGTCCCTGACAGGCTGACCTACCTGAGTCTCTGAGCTTTTC 4881 AGTCCAAATCTTTGCAAGGCTCAAAATGCCACAGAACCTCTCCTCTTCTCCCCACTCCCCATGGCAGGGACCGGACCATC 4961 CCTACATGCAACATGCTGTTCCTCCAGCCCCTCCCATTGCCATGGCAAAACAGGTACCTTTGGGGCATGGGGGCATTACA 5041 TGGGATGCTTGTGTAATCGACCACCTAGCCTTCTCTCTCCCCTCCCGTCCTCCCCCAGAATCACTTCCTAGGACACCCGA 5121 GCTGCTTGCCCAGGGTCCTGTTTCCCTGCTAACTCCAGAGAAGCATCCCAGGGCTTTGTGACAGTCTCTAATTCCCTTCC 5201 CTTCTCGTTAAGAATCATATTGTATAGTAGCTTTCAGACCATACAGTATTCATTGGGTTACTCCTATTATTATCAAGTAG 5281 CTGGAATTGTGAAGGTCGGAGTAGTTAGATCTTTAGCTTTTATTCCTTATTTTTTTGTATTACTCTCCATGTGTATAAAT 5361 TATTGATCATGTTGCTGGCTTTTATAAACTCTAAGCGAAGGAGGAGCACTGCCTCAGCCTTTGCACATGGTAATGAAGCA 5441 CTGTTTTTAAATAAAAGAGAGAAACACCATTAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 23543.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714646. RNA binding protein: AGO2. Condition:mildMNase
"PAR-CLIP data was present in GSM714647. RNA binding protein: AGO2. Condition:mildMNase
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 23543.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001082577 | 3UTR | UGACUCCUCAGGGGCUAAACUGCUCUUAGCUUAGAAUUAUGCUUUACUAGAGAUCUAGCAGAUAAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_014309 | 3UTR | AGAAGUCAUCGAUAGCAGCUUUUCCUCAAAUGUGUGACUCCUCAGGGGCUAAACUGCUCUUAGCUUAGAAUUAUGCUUUACUAGAGAUCUAGCAGAUAAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_014309 | 3UTR | AGUCUGAGGGGAGCUAGUGGAAAUCUAGACAAUAGAAGUCAUCGAUAGCAGCUUUUCCUCAAAUGUGUGACUCCUCAGGGGCUAAACUGCUCUUAGCUUAGAAUUAUGCUUUACUAGAGAUCUAGCAGAUAAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_001082577 | 3UTR | GCAGCUUUUCCUCAAAUGUGUGACUCCUCAGGGGCUAAACUGCUCUUAGCUUAGAAUUAUGCUUUACUAGAGAUCUAGCAGAUAAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_001082577 | 3UTR | AUAGCAGCUUUUCCUCAAAUGUGUGACUCCUCAGGGGCUAAACUGCUCUUAGCUUAGAAUUAUGCUUUACUAGAGAUCUAGCAGAUAAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_014309 | 3UTR | CUCUUAGCUUAGAAUUAUGCUUUACUAGAGAUCUAGCAGAUAAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000449924.2 | 3UTR | AGGCCUGGCUAUUGCAAUAUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000449924.2 | 3UTR | AGGCCUGGCUAUUGCAAUAUUUACUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM714646 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repA |
Location of target site | ENST00000449924.2 | 3UTR | AGUUCAUGAGGCCUGGCUAUUGCAAUAUUUACUAGUAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM714647 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repB |
Location of target site | ENST00000449924.2 | 3UTR | UCAUGAGGCCUGGCUAUUGCAAUAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000449924.2 | 3UTR | AGGCCUGGCUAUUGCAAUAUUUACUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000449924.2 | 3UTR | AGGCCUGGCUAUUGCAAUAUUUACUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 13 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000449924.2 | 3UTR | UUCAUGAGGCCUGGCUAUUGCAAUAUUUACUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 14 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000449924.2 | 3UTR | UUCAUGAGGCCUGGCUAUUGCAAUAUUUACUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
27 hsa-miR-628-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT039584 | CDC14A | cell division cycle 14A | 1 | 1 | ||||||||
MIRT039585 | AGO1 | argonaute 1, RISC catalytic component | 2 | 3 | ||||||||
MIRT039586 | TGFBRAP1 | transforming growth factor beta receptor associated protein 1 | 1 | 1 | ||||||||
MIRT039587 | LRP6 | LDL receptor related protein 6 | 1 | 1 | ||||||||
MIRT071876 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT097443 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 4 | ||||||||
MIRT100100 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT147692 | CBX4 | chromobox 4 | 2 | 2 | ||||||||
MIRT408248 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT442047 | LRAT | lecithin retinol acyltransferase | 2 | 2 | ||||||||
MIRT444412 | RAB3IP | RAB3A interacting protein | 2 | 2 | ||||||||
MIRT452599 | REPIN1 | replication initiator 1 | 2 | 2 | ||||||||
MIRT469515 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 8 | ||||||||
MIRT498192 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 2 | ||||||||
MIRT500151 | CREBBP | CREB binding protein | 2 | 2 | ||||||||
MIRT507319 | FAM60A | SIN3-HDAC complex associated factor | 2 | 6 | ||||||||
MIRT508343 | ZNF273 | zinc finger protein 273 | 2 | 6 | ||||||||
MIRT520480 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT522461 | MMP16 | matrix metallopeptidase 16 | 2 | 4 | ||||||||
MIRT547116 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT548675 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 2 | ||||||||
MIRT553756 | TARBP2 | TARBP2, RISC loading complex RNA binding subunit | 2 | 4 | ||||||||
MIRT559437 | ARSJ | arylsulfatase family member J | 2 | 2 | ||||||||
MIRT610490 | GPC4 | glypican 4 | 2 | 2 | ||||||||
MIRT644682 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT658214 | FBXO21 | F-box protein 21 | 2 | 2 | ||||||||
MIRT756083 | TP53 | tumor protein p53 | 4 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|